Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging
International Journal of Molecular Imaging · 28.09.2015 · 2015 · 1-10
DOI: 10.1155/2015/469047 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Imaging, erschienen am 28.09.2015. Verfasst von Elizabeth De Jesus und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, PA 19104, USA. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Intraoperative imaging can identify cancer cells in order to improve resection; thus fluorescent contrast agents have emerged. Our objective was to do a preclinical comparison of two fluorescent dyes, EC17 and OTL38, which both target folate receptor but have different fluorochromes. Materials . HeLa and KB cells lines were used for in vitro and in vivo comparisons of EC17 and OTL38 brightness, sensitivity, pharmacokinetics, and biodistribution. In vivo experiments were then performed in mice.
Results
The peak excitation and emission wavelengths of EC17 and OTL38 were 470/520 nm and 774/794 nm, respectively. In vitro , OTL38 required increased incubation time compared to EC17 for maximum fluorescence; however, peak signal-to-background ratio (SBR) was 1.4-fold higher compared to EC17 within 60 minutes ( p < 0.001 ). Additionally, the SBR for detecting smaller quantity of cells was improved with OTL38. In vivo , the mean improvement in SBR of tumors visualized using OTL38 compared to EC17 was 3.3 fold (range 1.48–5.43). Neither dye caused noticeable toxicity in animal studies.
Conclusions
In preclinical testing, OTL38 appears to have superior sensitivity and brightness compared to EC17. This coincides with the accepted belief that near infrared (NIR) dyes tend to have less autofluorescence and scattering issues than visible wavelength fluorochromes.
Autor:innen und Institutionen
- Division of Thoracic Surgery, Department of Surgery, University of Pennsylvania and Philadelphia VA Medical Center, Philadelphia, PA 19104, USA.
- On Target Laboratories, Inc., West Lafayette, IN 47906, USA.
- Departments of Biomedical Engineering and Chemistry, Emory University, Atlanta, GA 30322, USA.
- Department of Chemistry, Purdue University, West Lafayette, IN 47907, USA.
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
De Jesus, E., Keating, J. J., Kularatne, S. A., Jiang, J., Judy, R., Predina, J., Nie, S., Low, P., & Singhal, S. (2015). Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging. International Journal of Molecular Imaging, 2015, 1-10. https://doi.org/10.1155/2015/469047
Vancouver
De Jesus E, Keating JJ, Kularatne SA, Jiang J, Judy R, Predina J, et al. Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging. International Journal of Molecular Imaging. 2015;2015:1-10. doi:10.1155/2015/469047
BibTeX
@article{DeJesus2015,
author = {De Jesus, Elizabeth and Keating, Jane J and Kularatne, Sumith A and Jiang, Jack and Judy, Ryan and Predina, Jarrod and Nie, Shuming and Low, Philip and Singhal, Sunil},
title = {Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging},
journal = {International Journal of Molecular Imaging},
year = {2015},
volume = {2015},
pages = {1--10},
doi = {10.1155/2015/469047}
}
EUVIMED